Viewbix Inc. Receives Stockholder Approval for Acquisition of Quantum X Labs– A Hub for Quantum Algorithms, Navigation and Atomic Clocks

Rhea-AI Summary

Viewbix (Nasdaq: VBIX) received majority stockholder written consent to proceed with its previously announced acquisition of Quantum X Labs, entered under a definitive share purchase agreement dated Dec 15, 2025. The deal contemplates Viewbix acquiring 85%–100% of Quantum on a fully diluted basis and transfers Quantum's IP portfolio, including quantum algorithms, navigation/GPS alternatives, atomic clocks, and quantum error correction technology.

At closing Viewbix will issue common stock and pre-funded warrants equal to approximately 40% of its capital stock as of the Agreement Date (including 800,000 shares in a related private placement) with up to 12,702,847 additional shares or pre-funded warrants payable upon milestone achievement. Closing remains subject to due diligence and regulatory approvals; the company expects the transaction to close in the coming weeks and will file a Schedule 14C information statement.

Positive

• Acquisition targets 85%–100% of Quantum share capital
• Transfers IP in quantum algorithms, navigation, atomic clocks, and error correction
• Consideration included 800,000 related private placement shares
• Potential earnout up to 12,702,847 additional shares/warrants

Negative

• Issuance represents approximately 40% of Viewbix capital stock as of Dec 15, 2025
• Transaction remains subject to final due diligence and regulatory approvals
• Effective stockholder actions delayed until 20 days after Schedule 14C is furnished

News Market Reaction – VBIX

+4.27%

9 alerts

+4.27% News Effect

+13.1% Peak Tracked

-12.1% Trough Tracked

+$747K Valuation Impact

$18M Market Cap

0.9x Rel. Volume

On the day this news was published, VBIX gained 4.27%, reflecting a moderate positive market reaction. Argus tracked a peak move of +13.1% during that session. Argus tracked a trough of -12.1% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $747K to the company's valuation, bringing the market cap to $18M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Ownership to Acquire: 85%–100% Initial Equity Issuance: 40% Private Placement Shares: 800,000 shares +5 more

8 metrics

Ownership to Acquire 85%–100% Quantum X Labs issued and outstanding share capital

Initial Equity Issuance 40% VBIX capital stock as of Dec 15, 2025 at closing

Private Placement Shares 800,000 shares Common stock in related private placement at closing

Milestone Consideration 12,702,847 shares Potential additional common stock or pre-funded warrants on milestones

Effectiveness Delay 20 days Effective date after definitive Schedule 14C mailing

Price Move 7.19% VBIX 24h price change prior to this article

52-week Range $0.9605–$12.00 VBIX 52-week low and high before this news

Market Cap $16,325,700 VBIX market capitalization prior to the news

Market Reality Check

Price: $1.66 Vol: Volume 184,012 vs 20-day ...

normal vol

$1.66 Last Close

Volume Volume 184,012 vs 20-day average 162,426 (relative volume 1.13x). normal

Technical Price $1.64 is trading below 200-day MA at $3.79 and 86.33% below the 52-week high.

Peers on Argus

VBIX is up 7.19% on acquisition progress while peers show mixed moves: SCOR +1.3...

VBIX is up 7.19% on acquisition progress while peers show mixed moves: SCOR +1.38%, SJ +1.21%, ZDGE +5.31%, GIFT +4.67%, FENG -5.00%. No broad, one-direction sector move flagged.

Historical Context

5 past events · Latest: Jan 02 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 02	Quantum hub update	Positive	+7.2%	Spotlighted Quantum X Labs hub and reiterated acquisition timeline and scope.
Dec 22	Patent filing news	Positive	-1.9%	Provisional patent for quantum‑enhanced clinical trials plus deal timing reminder.
Dec 16	Definitive agreement	Positive	-24.8%	Definitive share purchase agreement to acquire 85%–100% of Quantum X Labs.
Nov 14	Revised deal terms	Positive	+2.5%	Updated term sheet reducing initial equity issuance to 40% with earn‑outs.
Nov 12	Asset sale & pivot	Positive	+1.8%	Sale of Cortex Media and disclosure of non‑binding term sheet for Quantum.

Pattern Detected

News around the Quantum X Labs transaction has produced mixed reactions: some acquisition milestones led to sharp selloffs, while others and strategic repositioning updates saw modest gains.

Recent Company History

Over the last few months, VBIX has steadily pivoted toward quantum technologies centered on Quantum X Labs. On Nov 12, 2025, it sold Cortex Media to refocus and disclosed a term sheet for Quantum. Subsequent updates on Nov 14, Dec 16, and Jan 2 detailed evolving acquisition terms, equity issuance structures, and Quantum’s portfolio. Today’s stockholder approval advances the same deal, following prior market reactions that alternated between sharp drawdowns and moderate gains to similar announcements.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-05

VBIX has an active S-3 shelf filed on Aug 5, 2025 expiring on Aug 5, 2028. The filing is not yet effective and shows 0 recorded usages so far, but it provides a framework the company could use for future registered offerings once effective.

Market Pulse Summary

This announcement advances VBIX’s shift into quantum technologies by securing stockholder approval f...

Analysis

This announcement advances VBIX’s shift into quantum technologies by securing stockholder approval for acquiring 85%–100% of Quantum X Labs, with closing still subject to due diligence and regulatory conditions. The structure involves issuing common stock and pre-funded warrants equal to about 40% of capital plus up to 12,702,847 additional shares tied to milestones. Historically, Quantum-related acquisition updates have triggered volatile single-day moves. Investors may track completion of remaining closing conditions, equity issuance levels, and subsequent integration milestones as the transaction progresses.

Key Terms

pre-funded warrants, quantum algorithms, atomic clocks, quantum error correction, +2 more

6 terms

pre-funded warrants financial

"Viewbix will issue common stock and pre-funded warrants representing approximately 40%..."

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

quantum algorithms technical

"a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation..."

Quantum algorithms are step-by-step recipes designed for quantum computers that use the unusual rules of quantum physics to tackle certain calculations much faster or differently than ordinary computers. They matter to investors because they can make some industries dramatically more efficient — speeding drug discovery, improving complex trading and optimization tasks, or threatening current encryption — so companies that master or are exposed to them may gain advantage or face new risks.

atomic clocks technical

"focused on quantum algorithms, navigation, and atomic clocks."

Atomic clocks are extremely precise timekeepers that measure seconds by counting the natural vibrations of atoms, like a metronome so steady it hardly ever drifts. For investors they matter because accurate timestamps and synchronized networks support high-speed trading, satellite navigation, communications and regulatory record-keeping—mistimed data or outages can lead to lost trades, compliance problems or market disruptions that affect asset values.

quantum error correction technical

"including an innovative patent for AI-Quantum Error Correction"

Quantum error correction is a set of methods for detecting and fixing mistakes in quantum computers by encoding fragile quantum information across multiple physical parts, much like using multiple copies or checksums to protect a sensitive digital file. For investors, it matters because reliable error correction is a key technical milestone that determines whether quantum machines can scale from experimental devices to practical tools that could disrupt computing, encryption, drug discovery and other industries.

stockholder approval regulatory

"it has received the requisite stockholder approval via written consent..."

Stockholder approval is formal consent given by a company’s shareholders, usually through a vote at a meeting or by proxy, for major actions such as mergers, asset sales, changes to corporate structure, or amendments to governance rules. Investors pay attention because the vote can enable or block steps that materially change a company’s direction, ownership or value—like neighbors voting to allow a major renovation that would alter a building’s use and worth.

schedule 14c regulatory

"file a preliminary information statement on Schedule 14C..."

Schedule 14C is an SEC filing that companies use to send an official information statement to shareholders when they are not asking for proxy votes. It lays out key facts about corporate actions—such as reorganizations, related-party transactions, or changes in governance—so investors can understand what’s happening without being asked to vote, like receiving a detailed neighborhood notice about a rule change rather than a petition. Because it provides formal, regulated disclosure, Schedule 14C helps investors verify claims, weigh potential impacts on ownership or value, and hold management accountable.

AI-generated analysis. Not financial advice.

The acquisition, which is subject to closing conditions, would encompass Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction

Tel Aviv, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that it has received the requisite stockholder approval via written consent of the majority of its stockholders (the “Stockholder Consent”) for its previously announced acquisition of Quantum X Labs Ltd. (“Quantum”), a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation, and atomic clocks.

The acquisition, which was entered into pursuant to the definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”), involves Viewbix acquiring between 85% and 100% of Quantum’s issued and outstanding share capital on a fully diluted basis.

Quantum operates portfolio companies developing innovative solutions in quantum-based navigation (including GPS alternatives), next-generation atomic clocks for precision timing, quantum algorithms for sectors such as transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies.

At closing, Viewbix will issue common stock and pre-funded warrants representing approximately 40% of its capital stock as of the Agreement Date (inclusive of 800,000 shares of common stock to be issued in a related private placement), with potential additional consideration of up to 12,702,847 shares of the Company’s common stock or pre-funded warrants upon achievement of specified post-closing milestones.

With stockholder approval secured via written consent, the transaction remains subject to satisfaction of remaining closing conditions, including final due diligence and regulatory approvals. The Company expects the acquisition to close in the coming weeks.

The Company intends to file a preliminary information statement on Schedule 14C (with the Securities and Exchange Commission on or about the date hereof. Pursuant to Delaware Law, the actions to be taken pursuant to the Stockholder Consent shall be effective on the 20^th day after the definitive information statement on Schedule 14C is mailed or furnished to the Company’s stockholders.

About Viewbix Inc.

Viewbix, through certain of its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., operates in the field of digital advertising. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software. The company offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

For more information about Viewbix, visit https://view-bix.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the timing and completion of the acquisition, the receipt of regulatory approvals, and the satisfaction of closing conditions related to the acquisition. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.

Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com

FAQ

What stake will Viewbix (VBIX) acquire in Quantum X Labs under the Dec 15, 2025 agreement?

Viewbix expects to acquire between 85% and 100% of Quantum's issued and outstanding share capital on a fully diluted basis.

How much equity will Viewbix (VBIX) issue at closing for the Quantum acquisition?

At closing Viewbix will issue common stock and pre-funded warrants representing about 40% of its capital stock as of the Agreement Date, including 800,000 related private placement shares.

Is there additional contingent consideration in the Viewbix (VBIX) acquisition of Quantum?

Yes; up to 12,702,847 additional shares or pre-funded warrants may be issued upon achievement of specified post-closing milestones.

When do Viewbix stockholder actions become effective under Delaware law for the Quantum deal?

Per Delaware law the actions become effective on the 20th day after the definitive Schedule 14C information statement is mailed or furnished to stockholders.

What closing conditions remain for Viewbix (VBIX) to complete the Quantum acquisition?

The transaction is still subject to final due diligence, regulatory approvals, and other closing conditions before closing is expected in the coming weeks.